Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1387, 2012-01, pp. : 5-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Adalimumab/etanercept/infliximab: Various toxicities: 41 case reports
Reactions Weekly, Vol. 1, Iss. 1297, 2010-01 ,pp. :
Adalimumab/etanercept: Various toxicities: 17 case reports
Reactions Weekly, Vol. 1, Iss. 1192, 2008-01 ,pp. :
Adalimumab/infliximab: Various toxicities: 30 case reports
Reactions Weekly, Vol. 1, Iss. 1251, 2009-01 ,pp. :
Adalimumab/efalizumab/infliximab: Psoriasis: 5 case reports
Reactions Weekly, Vol. 1, Iss. 1210, 2008-01 ,pp. :
Adalimumab/etanercept/rituximab: Various toxicities: case report
Reactions Weekly, Vol. 1, Iss. 1366, 2011-01 ,pp. :